CMPX vs NVR · $367.4M cap vs P/E 15, rev $10.52B
Compass Therapeutics Inc. (CMPX) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
CMPX currently screens at market cap $367.4M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the CMPX and NVR stock pages for the full models.
Not investment advice.